novel

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…

2 weeks ago
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) AgonistNxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 04, 2025 03:00 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…

2 weeks ago
Harper Collins Publishers India Presents master storyteller Ashwin Sanghi’s latest adventure-thriller in the chart-topping Bharat Collection, The Ayodhya AllianceHarper Collins Publishers India Presents master storyteller Ashwin Sanghi’s latest adventure-thriller in the chart-topping Bharat Collection, The Ayodhya Alliance

Harper Collins Publishers India Presents master storyteller Ashwin Sanghi’s latest adventure-thriller in the chart-topping Bharat Collection, The Ayodhya Alliance

Readers of smart adventure-thrillers and fans of the bestselling Bharat Collection need not wait any longer! NEW DELHI, June 2,…

2 months ago